Ad
related to: vertex pharmaceuticals
Search results
Insider Sale: EVP & CFO Charles F. Wagner Jr. Sells Shares of Vertex Pharmaceuticals Inc (VRTX)
GuruFocus.com via Yahoo Finance· 5 days agoOn May 28, 2024, Charles F. Wagner Jr., Executive Vice President and Chief Financial Officer of ...
3 No-Brainer Stocks to Buy in June | The Motley Fool
The Motley Fool· 3 days agoYou're probably familiar with the old adage, "April showers bring May flowers." Here's why they picked AbbVie (ABBV 3.15%), AstraZeneca (AZN 1.63%), and ...
Why Vertex Pharmaceuticals (VRTX) is a Top Growth Stock for the Long-Term
Zacks via Yahoo Finance· 5 days agoThis Score examines things like projected and historical earnings, sales, and cash flow to find...
Insider Sale: EVP & CFO Charles F. Wagner Jr. Sells Shares of Vertex Pharmaceuticals Inc (VRTX) By...
Investing.com· 5 days agoThe transaction was executed at a price of $454.79 per share, as detailed in the SEC Filing....
Should Abbott and DexCom Investors Be Worried About Vertex Pharmaceuticals? | The Motley Fool
The Motley Fool· 6 days agoIf you own shares of Abbott (ABT 0.44%) or DexCom (DXCM 0.31%), there's a looming threat to know...
Vertex Pharmaceuticals Incorporated (VRTX) is Attracting Investor Attention: Here is What You Should...
Zacks via Yahoo Finance· 5 days agoVertex (VRTX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is...
S&P 500 Giants Lead Five Healthy Stocks Near Buy Points
Investor's Business Daily· 4 days agoEli Lilly, Novo Nordisk, Vertex Pharmaceuticals, Intuitive Surgical and Universal Health are all...
Dow Jones Futures Fall As Growth Fears Mount; 7 Stocks Near Buy Points
Investor's Business Daily· 13 hours agoSpotify, Arm Holdings and ELF Beauty made strong moves, at least flirting with early entries. Vertex...
3 No-Brainer Stocks to Buy in June
Motley Fool via Yahoo Finance· 3 days agoHere's why they picked AbbVie (NYSE: ABBV), AstraZeneca (NASDAQ: AZN), and Vertex Pharmaceuticals (NASDAQ: VRTX) as no-brainer stocks to buy in June....
Vertex stock target lifted, retains Outperform on pain management drug potential By Investing.com
Investing.com· 4 days agoOn Friday, BMO Capital Markets adjusted its outlook on Vertex Pharmaceuticals (NASDAQ:VRTX)...
